Page last updated: 2024-10-24

cefixime and Cancer of Colon

cefixime has been researched along with Cancer of Colon in 1 studies

Cefixime: A third-generation cephalosporin antibiotic that is stable to hydrolysis by beta-lactamases.
cefixime : A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea, tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Research Excerpts

ExcerptRelevanceReference
"Cefuroxime axetil uptake was not dependent on energy and was not affected by dipeptides."1.29Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells. ( Dantzig, AH; Duckworth, DC; Tabas, LB, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dantzig, AH1
Duckworth, DC1
Tabas, LB1

Other Studies

1 other study available for cefixime and Cancer of Colon

ArticleYear
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
    Biochimica et biophysica acta, 1994, Apr-20, Volume: 1191, Issue:1

    Topics: Adenocarcinoma; Amino Acids; Biological Transport; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins;

1994